| efficacy | safety | suitability | cost | total | |
|---|---|---|---|---|---|
| diuretics | 6 | 9 | 9 | 10 | 34 |
| α receptor blockers | 5 | 6 | 9 | 8 | 28 |
| β receptor blockers | 7 | 7 | 9 | 8 | 31 |
| Ca2+channel blockers | 9 | 8 | 9 | 7 | 33 |
| ACE inhibitors | 8 | 8 | 9 | 7 | 32 |
| AUreceptor antagonists | 8 | 7 | 9 | 5 | 29 |
| α2 receptor agonists | 8 | 4 | 5 | 10 | 27 |
| adrenergic neuron blockers | 8 | 6 | × | 10 | × |
| ganglionic blocking drugs | 8 | 4 | × | ？ | × |
| vasodilator | 8 | 5 | × | 10 | × |